Case number 1:23-cv-00088
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 20, 2024 | 35 | CONSENT JUDGMENT. Signed by Chief District Judge Thomas S. Kleeh on 9/20/2024. (jb) (Case closed per TSK) (Entered: 09/20/2024) (4) |
| Sep 19, 2024 | 34 | Proposed Consent Judgment Order by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Taylor, Chad) (Entered: 09/19/2024) (4) |
| Jun 25, 2024 | 33 | PROTECTIVE ORDER. Signed by Chief District Judge Thomas S Kleeh on 6/25/2024. (dk) (Entered: 06/25/2024) (27) |
| Jun 24, 2024 | 32 | Proposed Protective Order by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Taylor, Chad) (Entered: 06/24/2024) (27) |
| Jun 12, 2024 | 31 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. DEFENDANT MYLAN PHARMACEUTICALS INC.S INITIAL DISCLOSURES PURSUANT TO RULE 26(A)(1). (Copland, Gordon) (Entered: 06/12/2024) (2) |
| Jun 12, 2024 | 30 | CERTIFICATE OF SERVICE by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. for Plaintiffs' Rule 26 Initial Disclosures. (Taylor, Chad) (Entered: 06/12/2024) (1) |
| Jun 5, 2024 | 29 | ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE ECF NOS. 22 , 24 , 25 , 26 as to Sarah E. Spencer, Robert L. Florence, Elizabeth M. Crompton, Tasneem A. Dharamsi. Signed by Chief District Judge Thomas S Kleeh on 6/5/2024. (mas) (Entered: 06/05/2024) (1) |
| May 28, 2024 | 28 | REPORT of Rule 26(f) Planning Meeting. (Attachments: # 1 Attachment Exhibit A to Meeting Report)(Taylor, Chad) (Entered: 05/28/2024) (Attachment Exhibit A to Meeting Report) (3) |
| May 28, 2024 | 28 | REPORT of Rule 26(f) Planning Meeting. (Attachments: # 1 Attachment Exhibit A to Meeting Report)(Taylor, Chad) (Entered: 05/28/2024) () (8) |
| May 9, 2024 | 24 | MOTION for Leave to Appear Pro Hac Vice (Robert L. Florence) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) () (4) |
| May 9, 2024 | 25 | MOTION for Leave to Appear Pro Hac Vice (Elizabeth M. Crompton) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) (Proposed Order) (1) |
| May 9, 2024 | 26 | MOTION for Leave to Appear Pro Hac Vice (Tasneem A. Dharamsi) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) (Proposed Order) (1) |
| May 9, 2024 | 24 | MOTION for Leave to Appear Pro Hac Vice (Robert L. Florence) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) (Proposed Order) (1) |
| May 9, 2024 | 25 | MOTION for Leave to Appear Pro Hac Vice (Elizabeth M. Crompton) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) () (4) |
| May 9, 2024 | 26 | MOTION for Leave to Appear Pro Hac Vice (Tasneem A. Dharamsi) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/09/2024) () (4) |
| May 9, 2024 | 27 | Pro Hac Vice Filing Fee in the amount of $600.00 for Robert L. Florence, Elizabeth M. Crompton and Tasneem A. Dharamsi has been paid. Receipt Number: 100003893. (jb) (Entered: 05/09/2024) (0) |
| May 7, 2024 | 23 | Pro Hace Vice Filing Fee in the amount of $200.00 paid for Sarah E. Spencer. Receipt Number: 100003891. (jb) (Entered: 05/07/2024) (0) |
| May 6, 2024 | 22 | MOTION for Leave to Appear Pro Hac Vice of Sarah E. Spencer by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 05/06/2024) () (2) |
| May 6, 2024 | 22 | MOTION for Leave to Appear Pro Hac Vice of Sarah E. Spencer by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 05/06/2024) (Proposed Order) (1) |
| Apr 26, 2024 | 21 | ANSWER to 20 Amended Complaint by Mylan Pharmaceuticals Inc..(O'Brien, William) (Entered: 04/26/2024) (14) |
| Apr 12, 2024 | 20 | Amended Complaint* (1) |
| Apr 11, 2024 | 19 | FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING CONFERENCE. ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 5/13/2024. Rule 26 Meeting Report due by 5/28/2024. Discovery due by 6/12/2024. Signed by Chief District Judge Thomas S. Kleeh on 4/11/2024. (jb) (Entered: 04/11/2024) (6) |
| Mar 22, 2024 | 17 | Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan, Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc... (Copland, Gordon) (Entered: 03/22/2024) (3) |
| Mar 22, 2024 | 18 | ANSWER to 1 Complaint, by Mylan Pharmaceuticals Inc..(Copland, Gordon) (Entered: 03/22/2024) (14) |
| Jan 25, 2024 | 16 | NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals Inc. (Copland, Gordon) (Entered: 01/25/2024) (2) |
| Jan 24, 2024 | 15 | WAIVER OF SERVICE Returned Executed by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. Mylan Pharmaceuticals Inc. waiver sent on 1/23/2024, answer due 3/25/2024. (Taylor, Chad) (Entered: 01/24/2024) (1) |
| Nov 16, 2023 | 14 | ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE [ECF NOS. 7 , 8 , 9 , 10 , 11 ]. Preston K. Ratliff II, Bruce M. Wexler, Mi Zhou, Jessica Stauring and Mark Russell Sperling are admitted to appear pro hac vice in this matter. Signed by Chief District Judge Thomas S Kleeh on 11/16/2023. (jb) (Entered: 11/16/2023) (1) |
| Nov 15, 2023 | 8 | MOTION for Leave to Appear Pro Hac Vice of Bruce M. Wexler by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) () (2) |
| Nov 15, 2023 | 7 | MOTION for Leave to Appear Pro Hac Vice of Preston K. Ratliff, II by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) () (2) |
| Nov 15, 2023 | 9 | MOTION for Leave to Appear Pro Hac Vice of Mi Zhou by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) () (2) |
| Nov 15, 2023 | 10 | MOTION for Leave to Appear Pro Hac Vice of Jessica Stauring by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) () (2) |
| Nov 15, 2023 | 7 | MOTION for Leave to Appear Pro Hac Vice of Preston K. Ratliff, II by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) (Proposed Order) (1) |
| Nov 15, 2023 | 11 | MOTION for Leave to Appear Pro Hac Vice of Mark Russell Sperling by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) (Proposed Order) (1) |
| Nov 15, 2023 | 9 | MOTION for Leave to Appear Pro Hac Vice of Mi Zhou by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) (Proposed Order) (1) |
| Nov 15, 2023 | 10 | MOTION for Leave to Appear Pro Hac Vice of Jessica Stauring by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) (Proposed Order) (1) |
| Nov 15, 2023 | 13 | Pro Hac Vice filing fee in the amount of $200.00 paid for Mark Russell Sperling. Receipt number 100003763. (jb) (Entered: 11/15/2023) (0) |
| Nov 15, 2023 | 12 | Pro Hac Vice filing fee in the amount of $800 paid for Preston K. Ratliff, II, Bruce M. Wexler, Mi Zhou, and Jessica Stauring. Receipt Number 100003762. (jb) (Entered: 11/15/2023) (0) |
| Nov 15, 2023 | 8 | MOTION for Leave to Appear Pro Hac Vice of Bruce M. Wexler by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) (Proposed Order) (1) |
| Nov 15, 2023 | 11 | MOTION for Leave to Appear Pro Hac Vice of Mark Russell Sperling by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: # 1 Proposed Order)(Taylor, Chad) (Entered: 11/15/2023) () (2) |
| Nov 8, 2023 | 6 | REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (mas) (Entered: 11/08/2023) (1) |
| Nov 8, 2023 | 5 | VERIFICATION OF ATTORNEY ADMISSION has been sent to attorneys Wexler, Ratliff, Zhou, Sperling and Stauring. (mas) (Entered: 11/08/2023) (1) |
| Nov 7, 2023 | 3 | Corporate Disclosure Statement by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. (mas) (Entered: 11/07/2023) (2) |
| Nov 7, 2023 | 2 | "Wrong event used, refiled as DE 6 ". Modified on 11/8/2023 (mas). (Main Document 2 replaced on 11/8/2023) (mas). (Entered: 11/07/2023) (1) |
| Nov 7, 2023 | 1 | Complaint* (1) |
